|
|
Volumn 13, Issue 4, 2000, Pages 227-232
|
|
Can COMT inhibitors improve cognitive functions in patients with Parkinson's disease?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2' FLUORO 3,4 DIHYDROXY 5 NITROBENZOPHENONE;
ANTIPARKINSON AGENT;
BENSERAZIDE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
ENTACAPONE;
LEVODOPA;
TOLCAPONE;
COGNITION;
DEGENERATIVE DISEASE;
ENZYME INHIBITION;
HUMAN;
NEUROLOGIC DISEASE;
NEUROTRANSMISSION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
REVIEW;
TREATMENT OUTCOME;
|
|
EID: 0034056755
PISSN: 11727047
EISSN: None
Source Type: Journal
DOI: 10.2165/00023210-200013040-00001 Document Type: Review |
|
Times cited : (4)
|
|
References (73)
|
